Cargando…

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases

In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases. The discovery of important bile acid signaling mechanisms, as well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meadows, Vik, Kennedy, Lindsey, Kundu, Debjyoti, Alpini, Gianfranco, Francis, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000431/ https://www.ncbi.nlm.nih.gov/pubmed/32064266 http://dx.doi.org/10.3389/fmed.2020.00015

Ejemplares similares

Biliary Epithelial Senescence in Liver Disease: There Will Be SASP
por: Meadows, Vik, et al.
Publicado: (2021)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
por: Zhou, Tianhao, et al.
Publicado: (2021)

Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis
por: Owen, Travis, et al.
Publicado: (2023)

Bile acid signaling and biliary functions
por: Jones, Hannah, et al.
Publicado: (2015)

Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling
por: Zhou, Tianhao, et al.
Publicado: (2022)

Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?
por: Baiocchi, Leonardo, et al.
Publicado: (2019)

Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies
por: Sato, Keisaku, et al.
Publicado: (2020)

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling
por: Kennedy, Lindsey, et al.
Publicado: (2020)

The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling
por: Mancinelli, Romina, et al.
Publicado: (2022)

Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice
por: Kennedy, Lindsey, et al.
Publicado: (2016)

Intercellular Communication between Hepatic Cells in Liver Diseases
por: Sato, Keisaku, et al.
Publicado: (2019)

Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma
por: Virani, Shohaib, et al.
Publicado: (2018)

Bile Acids and FXR: Novel Targets for Liver Diseases
por: Stofan, Mary, et al.
Publicado: (2020)

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma
por: Baiocchi, Leonardo, et al.
Publicado: (2022)

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases
por: Li, Yan, et al.
Publicado: (2018)

Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model
por: Ceci, Ludovica, et al.
Publicado: (2022)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
por: Bertolini, Anna, et al.
Publicado: (2022)

Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies
por: Kriegermeier, Alyssa, et al.
Publicado: (2020)

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
por: Ceci, Ludovica, et al.
Publicado: (2022)

Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis
por: Sato, Keisaku, et al.
Publicado: (2022)

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
por: Kim, Sun-Gi, et al.
Publicado: (2016)

Effects of Previous Kasai Surgery on Gut Microbiota and Bile Acid in Biliary Atresia With End-Stage Liver Disease
por: Song, Wei, et al.
Publicado: (2021)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Current Advances in Basic and Translational Research of Cholangiocarcinoma
por: Sato, Keisaku, et al.
Publicado: (2021)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
por: Fiaschini, Noemi, et al.
Publicado: (2022)

Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
por: Lewis, Phillip L., et al.
Publicado: (2018)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
por: Manley, Sharon, et al.
Publicado: (2015)

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Nobili, Valerio, et al.
Publicado: (2014)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

Author Correction: Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
por: Lewis, Phillip L., et al.
Publicado: (2023)

Surgery of the Liver and Bile Ducts
Publicado: (1904)

Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5
por: Abrigo, Johanna, et al.
Publicado: (2020)

Plasma bile acids in healthy green iguanas and iguanas with chronic liver diseases
por: Knotek, Zdenek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jrpaddaldqemebprg7rs72afjt